{
  "id": 18131003,
  "title": "Integrative Transcriptomic Meta-Analysis Reveals SIRT1-SNCA Correlation in Parkinson's Disease",
  "url": "https://urgent.news/2026/11/04/integrative-transcriptomic-meta-analysis-reveals-sirt1-snca",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-04T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.03.763624v1?rss=1"
  },
  "original_language": "en",
  "account": "Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects midbrain dopaminergic neurons, with no approved therapeutic treatments available. Identifying candidate molecular targets that are consistent across various models, such as postmortem human brain, iPSC-derived models, and dopaminergic cell lines, has been challenging, hindering clinical translation.\n\nTo address this issue, researchers conducted an integrative transcriptomic meta-analysis of 33 publicly available datasets from the mentioned model systems. They combined differential expression and functional enrichment analyses with STRING protein-protein interaction networks, followed by drug-gene interaction screening using a polyphenol panel. Surprisingly, resveratrol emerged as a common factor in all 33 comparisons, regardless of the model system, tissue, or genetic background.\n\nThe analysis revealed that resveratrol is associated with 30 distinct target genes, with SIRT1 being a recovered target in 6 of the comparisons, spanning all three model systems. Furthermore, the researchers resolved the SIRT1-SNCA relationship into four directional patterns that varied depending on the model system, with an inverse relationship observed in postmortem brain tissue and a positive relationship in acutely toxin-exposed cells. These findings provide evidence for a candidate, context-dependent resveratrol-SIRT1 axis in Parkinson's disease.",
  "summary": "Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects midbrain dopaminergic neurons without any approved therapy. Candidate molecular targets identified in one model are not always traceable across the postmortem, induced pluripotent stem cell (iPSC), and cell-based systems used to study PD, which complicates clinical translation. To address this gap, we performed an…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}